Jones Financial Companies
SVA

Jones Financial Companies’s Sinovac Biotech, Ltd SVA Stock Holding History

Jones Financial Companies’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
338
– – ﹤0.01% 5203
2026
Q1 		$0 Hold
338
– – ﹤0.01% 4952
2025
Q4 		$0 Buy
338
+300
+789% – ﹤0.01% 4639
2025
Q3 		$0 Buy
38
+2
+6% – ﹤0.01% 4407
2025
Q2 		$0 Buy
+36
New – ﹤0.01% 4211

Other funds holding SVA

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HI
Horizon Investments Charlotte, North Carolina $9.13B AUM 34.49% 1-Year Est. Return

Jones Financial Companies's SVA Position: Q2 2026 in Review

Jones Financial Companies held its Sinovac Biotech, Ltd (SVA) position steady in Q2 2026 at 338 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5203.

Jones Financial Companies first reported a position in SVA in Q2 2025 and has held it in 5 quarters since. 29 funds tracked by Wall St. Rank hold SVA as of Q2 2026.

  • Jones Financial Companies held 338 shares of Sinovac Biotech, Ltd worth $0 as of Q2 2026.
  • Jones Financial Companies left its Sinovac Biotech, Ltd share count unchanged in Q2 2026.
  • Sinovac Biotech, Ltd made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #5203 holding.
  • Jones Financial Companies first reported a position in Sinovac Biotech, Ltd in Q2 2025 and has held it in 5 quarters since.
  • 29 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.